EUVIMEDEUVIMED entdecken
Crossref

Characterization and therapeutic potential of two Kayvirus phages against methicillin-resistant S. aureus in a rat myositis model

Semra Tasdurmazli, Yasin Ali Cimen, Ebru Kanimdan, Fatma Bedia Karakaya Cimen, Buse Findikli, Mert Yılmaz, Emine Rumeysa Hekimoglu, Savas Ustunova, Mukaddes Esrefoglu, Abdurrahim Kocyigit, Luís D R Melo, Tulin Ozbek

European Journal of Clinical Microbiology & Infectious Diseases · 2026-11 · 45 (11) · 3343-3361

DOI: 10.1007/s10096-026-05604-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, online erschienen am 20.07.2026. Verfasst von Semra Tasdurmazli und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Science and Arts, Department of Molecular Biology and Genetics, Yıldız Technical University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Myositis, Phage Therapy, Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections. Die Arbeit nennt 83 Literaturangaben. Gefördert von: The Health Institutes of Türkiye (TUSEB).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Methicillin-resistant Staphylococcus aureus (MRSA) continues to compromise the efficacy of conventional antibiotics, highlighting the urgent need for alternative antimicrobial strategies. This study aimed to isolate, characterize, and evaluate the therapeutic potential of two strictly lytic bacteriophages, Staphylococcus phages EAS1 and EAS2, against MRSA, including their safety and efficacy in an in vivo myositis model. METHODS: EAS1 and EAS2 were isolated from wastewater and characterized using transmission electron microscopy, whole-genome sequencing, and in vitro functional assays. Genomic and comparative analyses were performed to assess genome organization and safety-related features. Therapeutic efficacy and toxicity were evaluated in a rat model of MRSA-induced myositis, with assessment of inflammatory mediators and histopathological tissue damage. RESULTS: Both phages exhibited broad and potent lytic activity against S. aureus, including MRSA strains, and demonstrated high physicochemical stability and biocompatibility. Both phages possessed large linear dsDNA genomes (∼138-140 kb) encoding over 240 CDSs without lysogeny, virulence, or antibiotic resistance genes and were classified within the Kayvirus genus based on comparative genomics. In vivo, phage treatment caused no detectable hepatic or renal toxicity. EAS2 treatment led to significant modulation of inflammatory mediators, including TNF-α, IL-10, NF-κB, and COX-2, and resulted in reduced histopathological tissue damage compared with untreated control and vancomycin-treated groups. CONCLUSION: These findings demonstrate the stability, safety, and therapeutic efficacy of bacteriophages EAS1 and EAS2, particularly EAS2, supporting phage therapy as a promising alternative approach for the treatment of MRSA infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyositisPhage TherapyMethicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsStaphylococcus PhagesAnimalsRatsDisease Models, AnimalGenome, ViralMaleWhole Genome Sequencing

Stichwörter der Autor:innen

Kayvirus phagesMethicillin-resistant S. aureusMyositis modelPhage therapy

Autor:innen und Institutionen

  • Faculty of Science and Arts, Department of Molecular Biology and Genetics, Yıldız Technical University, Istanbul, Turkey.
  • Faculty of Medicine, Department of Physiology, Bezmialem Vakif University, Istanbul, Turkey.
  • Faculty of Medicine, Department of Histology and Embryology, Yalova University, Yalova, Turkey.
  • Faculty of Medicine, Department of Biochemistry, Bezmialem Vakif University, Istanbul, Turkey.
  • Faculty of Medicine, Department of Histology and Embryology, Bezmialem Vakif University, Istanbul, Turkey.
  • Center of Biological Engineering, University of Minho, Braga, 4710-057, Portugal.

Förderung

  • The Health Institutes of Türkiye (TUSEB)

Zitieren

APA

Tasdurmazli, S., Cimen, Y. A., Kanimdan, E., Cimen, F. B. K., Findikli, B., Yılmaz, M., Hekimoglu, E. R., Ustunova, S., Esrefoglu, M., Kocyigit, A., Melo, L. D. R., & Ozbek, T. (2026). Characterization and therapeutic potential of two Kayvirus phages against methicillin-resistant S. aureus in a rat myositis model. European Journal of Clinical Microbiology & Infectious Diseases, 45(11), 3343-3361. https://doi.org/10.1007/s10096-026-05604-3

Vancouver

Tasdurmazli S, Cimen YA, Kanimdan E, Cimen FBK, Findikli B, Yılmaz M, et al. Characterization and therapeutic potential of two Kayvirus phages against methicillin-resistant S. aureus in a rat myositis model. European Journal of Clinical Microbiology & Infectious Diseases. 2026;45(11):3343-3361. doi:10.1007/s10096-026-05604-3

BibTeX
@article{Tasdurmazli2026,
  author = {Tasdurmazli, Semra and Cimen, Yasin Ali and Kanimdan, Ebru and Cimen, Fatma Bedia Karakaya and Findikli, Buse and Yılmaz, Mert and Hekimoglu, Emine Rumeysa and Ustunova, Savas and Esrefoglu, Mukaddes and Kocyigit, Abdurrahim and Melo, Luís D R and Ozbek, Tulin},
  title = {Characterization and therapeutic potential of two Kayvirus phages against methicillin-resistant S. aureus in a rat myositis model},
  journal = {European Journal of Clinical Microbiology & Infectious Diseases},
  year = {2026},
  volume = {45},
  number = {11},
  pages = {3343--3361},
  doi = {10.1007/s10096-026-05604-3}
}
Kostenlos starten →